Dr. McGarry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1210 Brace Rd
Ste 100
Cherry Hill, NJ 08034Phone+1 856-342-2445Fax+1 856-270-4085
Education & Training
University of RochesterResidency, Neurology, 2005 - 2008- University of RochesterInternship, Internal Medicine, 2004 - 2005
Rutgers Robert Wood Johnson Medical SchoolClass of 2004
Certifications & Licensure
NJ State Medical License 2011 - 2025
NY State Medical License 2008 - 2011- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- 1 citationsNegative findings from trials with NLY01 or deferiprone for Parkinson's disease - Author's reply.Andrew McGarry
The Lancet. Neurology. 2024-06-01 - 2 citationsContinuous Levodopa Delivery with an Intraoral Micropump System: An Open-Label Pharmacokinetics and Clinical Study.C Warren Olanow, Deborah McIntyre, Michele Matarazzo, Mika Leinonen, Andrew McGarry
Movement Disorders. 2024-06-01 - 1 citationsA Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Releas...C Warren Olanow, Robert A Hauser, Daniel J Burdick, Rohit Dhall, Joy Antonelle de Marcaida
Movement Disorders. 2024-02-01
Press Mentions
AAN Members Only: Sign in with Your AAN Member Credentials (Email or 6-Digit Member ID Number)January 10th, 2017
Can a GLP-1 Agonist Improve Parkinson's Symptoms?December 24th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
